Physician profile
Ian M Duensing
NPI 1417341314
$82,526.54
in general payments reported to CMS, 2019-2025
10 companies · $53K in 2025
The $53K reported for 2025 was more than what 89% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $13K · 2021: $13K · 2022: $325 · 2023: $1,434 · 2024: $1,623 · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Food and Beverage: $6,145 · Travel and Lodging: $4,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,227.60 |
| Food and Beverage | $6,145.33 |
| Travel and Lodging | $4,466.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $30,085.29 | 2024-2025 | Actis, Velys, Vistaseal |
| Smith+Nephew, INC. | $25,731.04 | 2020-2022 | |
| Ethicon US, LLC | $13,362.99 | 2024-2025 | Dermabond Prineo, Vistaseal, Stratafix |
| Depuy Synthes Products, INC. | $7,675.48 | 2025 | Velys |
| Zimmer Biomet Holdings, INC. | $2,464.09 | 2019-2025 | Persona, Rosa, Tapestry |
| Depuy Synthes Sales INC. | $2,391.31 | 2021-2025 | Attune, Velys, Reclaim |
| Stryker Corporation | $517.32 | 2019-2025 | Alphavent, Mako |
| Encore Medical, LP | $285.36 | 2024-2025 | Djo Surgical |
| Onkos Surgical, INC. | $13.66 | 2025 | Eleos Limb Salvage System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Duensing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.